Fenirofibrate is a fibrate agent and peroxisome proliferator-activated receptor alpha agonist used clinically to lower triglyceride levels in patients with hypertriglyceridemia. By upregulating lipoprotein… Read more
Fenirofibrate is a fibrate agent and peroxisome proliferator-activated receptor alpha agonist used clinically to lower triglyceride levels in patients with hypertriglyceridemia. By upregulating lipoprotein lipase activity and inhibiting hepatic VLDL synthesis, this compound plays a significant role in lipid regulation. This category provides essential reference standards for analytical testing, quality control, and impurity profiling. Laboratories utilize these high-purity materials to identify and quantify degradation products and process-related impurities that may arise during synthesis or storage. Furthermore, stable isotope-labelled compounds, such as deuterated analogues and glucuronide metabolites, are critical for accurate bioanalytical assays and pharmacokinetic studies. These standards enable precise quantification and method validation, ensuring compliance with regulatory requirements throughout the drug development lifecycle. By incorporating these specific analytical tools, researchers can effectively monitor compound stability and metabolic pathways in complex biological matrices.